Optina Diagnostics
1 known investors
Optina develops a retinal imaging and AI platform for diagnosing and managing Age-Related Macular Degeneration in eye care specialists and patients. The platform combines hyperspectral imaging technology with AI clinical decision support to improve early detection and disease monitoring.
AI & Machine LearningDigital HealthMedical Devices
Investors · 1
In the news
- Optina snags C$24.8m in DigitalDx-led Series A fundingventurecapitaljournal.com · 2021
- Optina raises $24 million to bolster AI-powered early Alzheimer detection device | BetaKitbetakit.com · 2021
- Optina Diagnostics Closes CA$24.8M Series A Funding Round - FinSMEsfinsmes.com · 2021
- Optina Diagnostics Closes an Oversubscribed Series-A Round of CA$24.8 millionprnewswire.com · 2021
- Supporting Optina Diagnostics with AI development and research funding - Centre de robotique et de vision industriellescrvi.ca · 2021
- CQDM is proud to be part of Optina Diagnostics' success - CQDMcqdm.org · 2018